We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Sep 2021
  • Code : CMI4630
  • Pages : 176
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Eczema, or dermatitis or atopic dermatitis, is a skin disease that results in inflammation of the skin. A person suffering from eczema suffers from rashes, redness of skin, and itchiness. This skin condition is most common in children and is also seen in the adult population. The symptoms of eczema are different from person to person. Dry itchy red skin, skin rashes, bumpy rashes, and blisters are some of the most common symptoms of this skin disease. Diagnosis of eczema is mostly based on physical examination and in few cases, skin biopsy is performed. The eczema therapeutics aims to control symptoms by reducing inflammation and relieve skin itchiness.

Market Dynamics

Market players are indulged in research and development activities for the treatment of eczema or atopic dermatitis, this is expected to increase the growth of the global eczema therapeutics market over the forecast period. For instance, the researchers at the Oregon Health & Science University, published their research in the New England Journal of Medicine online edition as well as presented their findings at a presentation at the European Academy of Dermatology and Venereology. Their research shows that drug Dupilumab, indicated for atopic dermatitis or eczema, alleviated the skin lesions and intense itching that were previously untreatable by standard medications and often impacted large areas of a trial participant’s body. In turn, the drug also reduced sleep deprivation, depression, and anxiety in participants who suffered from these symptoms because of the severity of eczema.

Increasing awareness for the treatment as well as management of eczema is expected to increase the growth of the global eczema therapeutics market over the forecast period. There are many organizations that are dealing with eczema. They are National Eczema Foundation, National Eczema Society, National Organization of Rare Diseases, International Eczema Council, and Eczema Foundation. Moreover, the Eczema Foundation is under partnership with other institutions and organizations, in order to increase knowledge as well as availability of the treatment options for the eczema, such as Association of the people affected with Atopic Dermatitis, Imperial College London, Eczema Outreach Support, French Association for the prevention of Allergies, and International Society of Atopic Dermatitis etc.

Key features of the study:

  • This report provides an in-depth analysis of global eczema therapeutics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global eczema therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi S.A., Encore Dermatology Inc., AbbieVie Inc., F. Hoffmann-La Roche AG, Novartis AG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Anacor Pharmaceuticals Inc., Meda AB, GlaxoSmithKline plc, AstraZeneca plc, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global eczema therapeutics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the eczema therapeutics market

Detailed Segmentation:

  • Global Eczema Therapeutics Market, By Treatment:
    • Corticosteroids
    • Emollients/Moisturizers
    • Antihistamines
    • Calcineurin inhibitors
    • Antibiotics
    • Immunomodulators
    • Interleukin inhibitors
  • Global Eczema Therapeutics Market, By Distribution Channel:
    • Hospitals and Clinics
    • Retail Pharmacies
    • Online Pharmacies
  • Global Eczema Therapeutics Market, By Region:
    • North America
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Treatment:
        • Corticosteroids
        • Emollients/Moisturizers
        • Antihistamines
        • Calcineurin inhibitors
        • Antibiotics
        • Immunomodulators
        • Interleukin inhibitors
      • By Distribution Channel:
        • Hospitals and Clinics
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Sanofi S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Encore Dermatology Inc.
    • AbbieVie Inc.
    • Hoffmann-La Roche AG
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Astellas Pharma Inc.
    • Anacor Pharmaceuticals Inc.
    • Meda AB
    • GlaxoSmithKline plc
    • AstraZeneca plc.
    • Pfizer Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Treatment
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Recent Product Launch/Approval
    • Epidemiology
    • Mergers and Acquisitions
  4. Global Eczema Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic
    • Impact on Supply Chain
    • Impact on Research and Development
    • Government Initiatives
  5. Global Eczema Therapeutics Market, By Treatment, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Emollients/Moisturizers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Antihistamines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Calcineurin inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Immunomodulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Interleukin inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  6. Global Eczema Therapeutics Market, By Distribution Channel, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  7. Global Eczema Therapeutics Market, By Region, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Sanofi S.A.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Encore Dermatology Inc
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • AbbieVie Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Hoffmann-La Roche AG
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Novartis AG
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Regeneron Pharmaceuticals Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Astellas Pharma Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Anacor Pharmaceuticals Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Meda AB
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • GlaxoSmithKline plc
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • AstraZeneca plc,
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 39 market data tables and 27 figures on "Eczema Therapeutics Market” - Global Forecast to 2028.

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.